tiprankstipranks
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market
DRUG
Bright Minds Biosciences
RESEARCH TOOLSreports
Want to see DRUG full AI Analyst Report?

Bright Minds Biosciences (DRUG) Income Statement

281 Followers

Bright Minds Biosciences Income Statement

Last quarter (Q1 2026), Bright Minds Biosciences's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Bright Minds Biosciences's net income was C$-7.57M. See Bright Minds Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Dec 24Sep 23Sep 22Sep 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -76.87KC$ -73.36KC$ -72.45KC$ -6.04KC$ 0.00
Operating Expenses
C$ 13.82MC$ 2.74MC$ 7.29MC$ 14.73MC$ 8.60M
Depreciation and Amortization
C$ 76.87KC$ 73.36KC$ 72.45KC$ 6.04KC$ 8.62M
EBITDA
C$ -13.86MC$ -2.72MC$ -7.28MC$ -14.73MC$ 0.00
Operating Income
C$ -13.94MC$ -2.81MC$ -7.37MC$ -14.74MC$ -8.76M
Other Income/Expenses
C$ 1.71MC$ 11.88KC$ -5.56KC$ -232.93KC$ -27.64K
Pretax Income
C$ -12.23MC$ -2.80MC$ -7.37MC$ -14.96MC$ -8.65M
Net Income
C$ -12.23MC$ -2.80MC$ -7.37MC$ -15.19MC$ -8.52M
Per Share Metrics
Basic EPS
C$ -1.78C$ -0.65C$ -1.98C$ -6.15C$ -4.74
Diluted EPS
C$ -1.78C$ -0.65C$ -1.98C$ -6.15C$ -4.74
Weighted Average Shares Outstanding
 6.88M 4.31M 3.72M 2.47M 1.79M
Weighted Average Shares Outstanding (Diluted)
 6.88M 4.31M 3.72M 2.47M 1.79M
Currency in CAD

Bright Minds Biosciences Earnings and Revenue History